Cargando…

Updates in the Treatment of Peripheral T-Cell Lymphomas

Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of rare hematologic malignancies accounting for less than 10% of non-Hodgkin lymphomas. The 2016 classification of World Health Organization recognized 29 different entities of PTCLs. These subgroups are characterized by different m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Khalil, Michot, Jean-Marie, Ribrag, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235949/ https://www.ncbi.nlm.nih.gov/pubmed/34188559 http://dx.doi.org/10.2147/JEP.S262344

Ejemplares similares

Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma
por: Saleh, Khalil, et al.
Publicado: (2022)

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors
por: Armand, Jean-Pierre, et al.
Publicado: (2007)

Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas
por: Saleh, Khalil, et al.
Publicado: (2020)

An update on the management of peripheral T-cell lymphoma and emerging treatment options
por: Phillips, Adrienne A, et al.
Publicado: (2011)

CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
por: Saleh, Khalil, et al.
Publicado: (2023)

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
por: Lu, Guang, et al.
Publicado: (2023)

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma
por: Quivoron, Cyril, et al.
Publicado: (2022)

Peripheral T-Cell Lymphoma: Review and Updates of Current Management Strategies
por: Tang, Tiffany, et al.
Publicado: (2010)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
por: Huang, Wen-Rong, et al.
Publicado: (2018)

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
por: Michot, Jean-Marie, et al.
Publicado: (2021)

Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
por: Barbarotta, Lisa, et al.
Publicado: (2015)

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy
por: Michot, Jean-Marie, et al.
Publicado: (2021)

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
por: Zhang, Ping, et al.
Publicado: (2020)

Treatment approaches in relapsed or refractory peripheral T-cell lymphomas
por: Foster, Cheryl, et al.
Publicado: (2020)

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
por: Coiffier, Bertrand, et al.
Publicado: (2014)

Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat
por: Duvic, Madeleine, et al.
Publicado: (2007)

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Bodiford, Andrew, et al.
Publicado: (2014)

New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
por: Reimer, Peter
Publicado: (2015)

Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas
por: Sorigue, Marc, et al.
Publicado: (2022)

Therapeutic options in peripheral T cell lymphoma
por: Zhang, Yaping, et al.
Publicado: (2016)

Genetic Landscape of Peripheral T-Cell Lymphoma
por: Hathuc, Vivian, et al.
Publicado: (2022)

Peripheral T-Cell Lymphomas: Therapeutic Approaches
por: Sibon, David
Publicado: (2022)

Controversies in the Treatment of Peripheral T-cell Lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2020)

An Update in Management of Noncutaneous T-Cell Lymphomas
por: Hwang, Y. Y., et al.
Publicado: (2010)

Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma
por: Abdullah, Shahed Azzam Ahmed, et al.
Publicado: (2023)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)

Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
por: Pileri, Stefano A., et al.
Publicado: (2021)

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
por: Makita, Shinichi, et al.
Publicado: (2018)

Follicular lymphoma: updates for pathologists
por: Khanlari, Mahsa, et al.
Publicado: (2022)

Update on peripheral ulcerative keratitis
por: Yagci, Ayse
Publicado: (2012)

Updates in diabetic peripheral neuropathy
por: Juster-Switlyk, Kelsey, et al.
Publicado: (2016)

The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review
por: Ridwansyah, Hastono, et al.
Publicado: (2023)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
por: Hood, Katelyn, et al.
Publicado: (2016)

Biomarker-driven management strategies for peripheral T cell lymphoma
por: Mulvey, Erin, et al.
Publicado: (2020)

Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas
por: Satou, Akira, et al.
Publicado: (2022)

Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
por: Stuver, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s7a3va49c3uf4t0an9o67c5u3q